No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial.Chopera D.R., Mann J.K., Mwimanzi P., Omarjee S., Kuang X.T., Ndabambi N., Goodier S., Martin E., Naranbhai V.[...], Brockman M.A.View abstractCited forNUCLEOTIDE SEQUENCEStrain100365_200CategorySequencesSourceUniProtKB unreviewed (TrEMBL)PubMedEurope PMCPLoS One 8:e71758-e71758 (2013)Cited in99+